1-3 of 3
Ina Oehme
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Remission instead of eradication? MEK inhibition in primary refractory childhood LCH

Free
Alexander Desuki, Claudia Paret, Ina Oehme, Heike Peterziel, Olaf Witt, Francesca Alt, Olaf Beck, Khalifa ElMalki, Arthur Wingerter, Julia Heider, Achim Reckmann, Gundula Staatz, Thomas Lehrnbecher, Joerg Faber, Milen Minkov, Alexandra Russo
Journal: Blood
Blood (2025) 146 (Supplement 1): 7281.
https://doi.org/10.1182/blood-2025-7281
Published: 2025
Journal Articles

Epigenetic Drug Treatment Globally Induces Cryptic Transcription Start Sites Encoded in Long Terminal Repeats

Free
Michael Daskalakis, David Brocks, Christopher Schmidt, Daofeng Li, Jing Li, Hyo S. Jang, Bo Zhang, Daniel B Lipka, Johanna Schott, Holger Bierhoff, Yassen Assenov, Monika Helf, Alzbeta Ressnerova, Anders Lindroth, Simon Haas, Marieke A. G. Essers, Charles D. Imbusch, Benedikt Brors, Ina Oehme, Olaf Witt, Michael Lübbert, MD, Georg Stoecklin, Clarissa Gerhäuser, Christopher C Oakes, PhD, Ting Wang, Christoph Plass
Journal: Blood
Blood (2016) 128 (22): 3931.
https://doi.org/10.1182/blood.V128.22.3931.3931
Published: 2016
Journal Articles

Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells

Free
Nathalie Fiegler, Sonja Textor, Annette Arnold, Alexander Rölle, Ina Oehme, Kai Breuhahn, Gerhard Moldenhauer, Mathias Witzens-Harig, Adelheid Cerwenka
Journal: Blood
Blood (2013) 122 (5): 684–693.
https://doi.org/10.1182/blood-2013-02-482513
Published: 2013
Includes: Supplemental data